AWAT1

gene
On this page

Summary

AWAT1 (acyl-CoA wax alcohol acyltransferase 1, HGNC:23252) is a protein-coding gene on chromosome Xq13.1, encoding Acyl-CoA wax alcohol acyltransferase 1 (Q58HT5). Acyltransferase that catalyzes the formation of ester bonds between fatty alcohols and fatty acyl-CoAs to form wax monoesters.

The protein encoded by this gene belongs to the diacylglycerol acyltransferase family. It esterifies long chain (wax) alcohols with acyl-CoA-derived fatty acids to produce wax esters. Wax esters are enriched in sebum, suggesting that this enzyme plays a central role in lipid metabolism in skin. Consistent with this observation, this protein is predominantly expressed in the sebaceous gland of the skin.

Source: NCBI Gene 158833 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 58 total
  • Druggable target: yes
  • MANE Select transcript: NM_001013579

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:23252
Approved symbolAWAT1
Nameacyl-CoA wax alcohol acyltransferase 1
LocationXq13.1
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000204195
Ensembl biotypeprotein_coding
OMIM300924
Entrez158833

Gene structure

Transcript identifiers

Ensembl transcripts: 2 — 1 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000374521, ENST00000480702

RefSeq mRNA: 1 — MANE Select: NM_001013579 NM_001013579

CCDS: CCDS35321

Canonical transcript exons

ENST00000374521 — 7 exons

ExonStartEnd
ENSE000014637177024013670240659
ENSE000014637187023973570239934
ENSE000014637207023821270238383
ENSE000014637227023704470237248
ENSE000035195337023465570234771
ENSE000035273517023571670235823
ENSE000035903227023606970236139

Expression profiles

Bgee: expression breadth broad, 43 present calls, max score 93.12.

Top tissues by expression

192 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
upper leg skinUBERON:000426293.12gold quality
mammalian vulvaUBERON:000099778.36gold quality
myocardiumUBERON:000234962.14gold quality
endothelial cellCL:000011561.91gold quality
skeletal muscle tissue of biceps brachiiUBERON:000450254.16gold quality
biceps brachiiUBERON:000150753.75gold quality
mucosa of sigmoid colonUBERON:000499351.78gold quality
buccal mucosa cellCL:000233651.04gold quality
quadriceps femorisUBERON:000137748.82gold quality
vastus lateralisUBERON:000137948.63gold quality
colonic mucosaUBERON:000031747.81gold quality
zone of skinUBERON:000001447.49gold quality
skin of abdomenUBERON:000141646.89gold quality
nippleUBERON:000203046.65silver quality
sural nerveUBERON:001548846.60gold quality
substantia nigra pars reticulataUBERON:000196645.43gold quality
right uterine tubeUBERON:000130245.27silver quality
substantia nigra pars compactaUBERON:000196544.99gold quality
calcaneal tendonUBERON:000370144.16silver quality
deltoidUBERON:000147643.66gold quality
adult organismUBERON:000702343.60gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451143.37gold quality
skeletal muscle tissueUBERON:000113443.30gold quality
skin of legUBERON:000151142.96gold quality
pharyngeal mucosaUBERON:000035542.81gold quality
bone marrow cellCL:000209242.58gold quality
secondary oocyteCL:000065542.57gold quality
gingivaUBERON:000182842.37gold quality
epithelium of nasopharynxUBERON:000195142.06gold quality
inferior vagus X ganglionUBERON:000536341.64gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no1.95

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

22 targeting AWAT1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-9-5P100.0072.282361
HSA-MIR-3163100.0077.238605
HSA-MIR-4778-3P99.9370.401818
HSA-MIR-605-3P99.8869.221833
HSA-MIR-182-5P99.8774.032589
HSA-MIR-197699.7465.481127
HSA-MIR-4524A-3P99.7266.852406
HSA-MIR-472999.6972.184233
HSA-MIR-127599.4767.902749
HSA-MIR-391599.4568.491905
HSA-MIR-3688-5P99.1269.671091
HSA-MIR-625-5P99.0268.642031
HSA-MIR-939-3P98.9765.072347
HSA-MIR-423-5P98.6967.481522
HSA-MIR-3184-5P98.5667.131491
HSA-MIR-429098.5165.17907
HSA-MIR-442197.9964.89701
HSA-MIR-5699-3P97.8165.00861
HSA-MIR-466097.7967.441328
HSA-MIR-214-5P97.3466.50617
HSA-MIR-365796.3366.29608
HSA-MIR-5002-3P95.7567.04542

Literature-anchored findings (GeneRIF, showing 1)

  • analysis of AWAT1 and AWAT2 substrate specificity and differentiation-specific expression pattern (PMID:15671038)

Cross-species orthologs

9 orthologs

OrganismSymbolGene ID
mus_musculusAwat1ENSMUSG00000015665
rattus_norvegicusAwat1ENSRNOG00000026231
drosophila_melanogasterCG1941FBGN0033214
drosophila_melanogasterDgat2FBGN0033215
drosophila_melanogasterCG1946FBGN0033216
caenorhabditis_elegansWBGENE00010296
caenorhabditis_elegansWBGENE00019464
caenorhabditis_elegansWBGENE00020910
caenorhabditis_elegansWBGENE00021818

Paralogs (6): DGAT2 (ENSG00000062282), MOGAT3 (ENSG00000106384), MOGAT1 (ENSG00000124003), AWAT2 (ENSG00000147160), MOGAT2 (ENSG00000166391), DGAT2L6 (ENSG00000184210)

Protein

Protein identifiers

Acyl-CoA wax alcohol acyltransferase 1Q58HT5 (reviewed: Q58HT5)

Alternative names: Diacylglycerol O-acyltransferase 2-like protein 3, Diacylglycerol acyltransferase 2, Long-chain-alcohol O-fatty-acyltransferase 1

All UniProt accessions (1): Q58HT5

UniProt curated annotations — full annotation on UniProt →

Function. Acyltransferase that catalyzes the formation of ester bonds between fatty alcohols and fatty acyl-CoAs to form wax monoesters. Shows a strong preference for decyl alcohol (C10), with less activity towards C16 and C18 alcohols. Shows a strong preference for saturated acyl-CoAs.

Subcellular location. Endoplasmic reticulum membrane.

Tissue specificity. Predominantly expressed in skin, where it is limited to the sebaceous gland. Expressed in more mature, centrally located cells just before their rupture and sebum release. Also expressed in all tissues except spleen. Expressed at higher level in thymus, prostate and testis.

Similarity. Belongs to the diacylglycerol acyltransferase family.

RefSeq proteins (1): NP_001013597* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR007130DAGATFamily

Pfam: PF03982

Enzyme classification (BRENDA):

  • EC 2.3.1.75 — long-chain-alcohol O-fatty-acyltransferase (BRENDA: 24 organisms, 473 substrates, 10 inhibitors, 48 Km, 37 kcat entries)

Substrate kinetics (BRENDA)

17 substrates with measured Km, best-characterized 15. Km ranges are aggregated across organisms/conditions.

SubstrateKm (mM)Measurements
PALMITOYL-COA0.0031–0.0296
ARACHIDONOYL-COA0.2263–0.29724
DECANOYL-COA0.001–0.01764
EICOSAPENTAENOYL-COA0.1016–0.13124
LAUROYL-COA0.0001–0.02594
MYRISTOYL-COA0.0039–0.01854
OCTADECATRIENOYL-COA0.2809–0.28474
OCTANOYL-COA0.0123–0.02994
STEAROYL-COA0.0192–0.07594
11-CIS-RETINOL0.02621
13-CIS-RETINOL0.03521
9-CIS-RETINOL0.02381
ALL-TRANS-RETINOL0.02361
HEXADECANOL0.0441
HEXAN-1-OL2.41

Catalyzed reactions (Rhea), 11 shown:

  • hexadecan-1-ol + hexadecanoyl-CoA = hexadecyl hexadecanoate + CoA (RHEA:38167)
  • 1,2-di-(9Z-octadecenoyl)-sn-glycerol + (9Z)-octadecenoyl-CoA = 1,2,3-tri-(9Z-octadecenoyl)-glycerol + CoA (RHEA:38219)
  • decan-1-ol + (9Z)-octadecenoyl-CoA = decyl (9Z)-octadecenoate + CoA (RHEA:38223)
  • hexadecan-1-ol + (9Z)-octadecenoyl-CoA = hexadecyl (9Z)-octadecenoate + CoA (RHEA:38227)
  • (9Z)-hexadecen-1-ol + (9Z)-octadecenoyl-CoA = 1-O-(9Z)-hexadecenyl (9Z)-octadecenoate + CoA (RHEA:38231)
  • octadecan-1-ol + (9Z)-octadecenoyl-CoA = octadecyl (9Z)-octadecenoate + CoA (RHEA:38235)
  • (9Z)-octadecen-1-ol + (9Z)-octadecenoyl-CoA = 1-O-(9Z)-octadecenyl (9Z)-octadecenoate + CoA (RHEA:38239)
  • eicosan-1-ol + (9Z)-octadecenoyl-CoA = 1-O-eicosanyl (9Z)-octadecenoate + CoA (RHEA:38243)
  • hexadecan-1-ol + (9Z)-hexadecenoyl-CoA = hexadecyl (9Z)-hexadecenoate + CoA (RHEA:38247)
  • hexadecan-1-ol + octadecanoyl-CoA = hexadecyl octadecanoate + CoA (RHEA:38251)
  • a long chain fatty alcohol + a fatty acyl-CoA = a long-chain alcohol wax ester + CoA (RHEA:38443)

UniProt features (3 total): transmembrane region 2, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q58HT5-F193.130.83

Function

Pathways and Gene Ontology

Reactome pathways

6 pathways

IDPathway
R-HSA-2142753Arachidonate metabolism
R-HSA-9640463Wax biosynthesis
R-HSA-1430728Metabolism
R-HSA-556833Metabolism of lipids
R-HSA-8848584Wax and plasmalogen biosynthesis
R-HSA-8978868Fatty acid metabolism

MSigDB gene sets: 33 (showing top): GOBP_LONG_CHAIN_FATTY_ACID_METABOLIC_PROCESS, GOBP_MONOCARBOXYLIC_ACID_METABOLIC_PROCESS, GOBP_LIPID_METABOLIC_PROCESS, GOBP_ORGANIC_ACID_METABOLIC_PROCESS, GOBP_LIPID_BIOSYNTHETIC_PROCESS, GOBP_UNSATURATED_FATTY_ACID_METABOLIC_PROCESS, GOBP_FATTY_ACID_DERIVATIVE_BIOSYNTHETIC_PROCESS, GOBP_ARACHIDONATE_METABOLIC_PROCESS, GOBP_FATTY_ACID_DERIVATIVE_METABOLIC_PROCESS, DURCHDEWALD_SKIN_CARCINOGENESIS_UP, GOCC_NUCLEAR_OUTER_MEMBRANE_ENDOPLASMIC_RETICULUM_MEMBRANE_NETWORK, GOBP_FATTY_ACID_METABOLIC_PROCESS, GOCC_ORGANELLE_SUBCOMPARTMENT, GOMF_ACYLTRANSFERASE_ACTIVITY, GOMF_O_ACYLTRANSFERASE_ACTIVITY

GO Biological Process (3): lipid metabolic process (GO:0006629), wax biosynthetic process (GO:0010025), arachidonate metabolic process (GO:0019369)

GO Molecular Function (4): long-chain-alcohol O-fatty-acyltransferase activity (GO:0047196), obsolete O-acyltransferase activity (GO:0008374), transferase activity (GO:0016740), acyltransferase activity (GO:0016746)

GO Cellular Component (3): endoplasmic reticulum membrane (GO:0005789), endoplasmic reticulum (GO:0005783), membrane (GO:0016020)

Reactome top-level categories

Rollup of top-4 pathways:

CategoryPathways
Metabolism of lipids2
Fatty acid metabolism1
Wax and plasmalogen biosynthesis1
Metabolism1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
primary metabolic process1
wax metabolic process1
fatty acid derivative biosynthetic process1
long-chain fatty acid metabolic process1
icosanoid metabolic process1
unsaturated fatty acid metabolic process1
olefinic compound metabolic process1
acyltransferase activity, transferring groups other than amino-acyl groups1
catalytic activity1
transferase activity1
organelle membrane1
nuclear outer membrane-endoplasmic reticulum membrane network1
endoplasmic reticulum subcompartment1
cytoplasm1
endomembrane system1
intracellular membrane-bounded organelle1
cellular anatomical structure1

Protein interactions and networks

STRING

762 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
AWAT1ELOVL2Q9NXB9866
AWAT1SLC27A1Q6PCB7843
AWAT1ELOVL3Q9HB03755
AWAT1FABP4P15090741
AWAT1DGAT1O75907733
AWAT1ELOVL1Q9BW60718
AWAT1ACSL5Q9ULC5638
AWAT1SREBF1P36956601
AWAT1SCDO00767576
AWAT1PNPLA2Q96AD5575
AWAT1MTTPP55157542
AWAT1APOBP04114520
AWAT1ACACAQ13085520
AWAT1PPARAQ07869488
AWAT1FAR2Q96K12471

IntAct

0 interactions, top by confidence:

ESM2 similar proteins: A2ADU8, A2ADU9, A6QP72, F6ZFR0, O74850, O94361, P51658, Q08650, Q16635, Q22267, Q32LS6, Q3UN02, Q41745, Q4V8A1, Q4V9F0, Q502J0, Q54GC1, Q58HT5, Q58NB6, Q5F3X0, Q62730, Q6CF02, Q6E1M8, Q6E213, Q6IV76, Q6IV77, Q6IV78, Q6IV82, Q6IV83, Q6IV84, Q6IWY1, Q6P342, Q6PAZ3, Q6ZPD8, Q7TQA3, Q8LG50, Q8N3Y7, Q8TC12, Q8VD48, Q91WF0

Diamond homologs: A2ADU8, A2ADU9, A6QP72, K7K424, O74850, Q08650, Q28C88, Q2KHS5, Q3KPP4, Q3SYC2, Q4V9F0, Q54GC1, Q58HT5, Q5FVP8, Q5M7F4, Q5M8H5, Q6E1M8, Q6E213, Q6P342, Q6PAZ3, Q6ZPD8, Q70VZ7, Q70VZ8, Q75BY0, Q80W94, Q86VF5, Q91ZV4, Q96PD6, Q96PD7, Q96UY1, Q96UY2, Q9ASU1, Q9DCV3, A1A442, Q9ZVN2

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

58 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance33
Likely benign4
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

654 predictions. Top by Δscore:

VariantEffectΔscore
X:70236064:CTCA:Cacceptor_loss1.0000
X:70236065:TCA:Tacceptor_loss1.0000
X:70236066:CA:Cacceptor_loss1.0000
X:70236068:GGT:Gacceptor_gain1.0000
X:70236140:GTA:Gdonor_loss1.0000
X:70236141:TAAG:Tdonor_loss1.0000
X:70238206:CTTTA:Cacceptor_loss1.0000
X:70238207:TTTA:Tacceptor_loss1.0000
X:70238208:TTA:Tacceptor_loss1.0000
X:70238209:TA:Tacceptor_loss1.0000
X:70238211:GGT:Gacceptor_gain1.0000
X:70240120:C:CAacceptor_gain1.0000
X:70240130:T:Aacceptor_gain1.0000
X:70240133:CAGT:Cacceptor_loss1.0000
X:70240134:A:AGacceptor_gain1.0000
X:70240134:AGTT:Aacceptor_gain1.0000
X:70240134:AGTTG:Aacceptor_gain1.0000
X:70240135:G:GAacceptor_gain1.0000
X:70240135:GT:Gacceptor_gain1.0000
X:70240135:GTT:Gacceptor_gain1.0000
X:70240135:GTTG:Gacceptor_gain1.0000
X:70240135:GTTGG:Gacceptor_gain1.0000
X:70234767:CATCT:Cdonor_gain0.9900
X:70234769:TCT:Tdonor_gain0.9900
X:70234772:G:GGdonor_gain0.9900
X:70236061:T:TAacceptor_gain0.9900
X:70236064:CTCAG:Cacceptor_gain0.9900
X:70236065:TCAG:Tacceptor_gain0.9900
X:70236066:CAGGT:Cacceptor_gain0.9900
X:70236067:A:AGacceptor_gain0.9900

AlphaMissense

2162 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
X:70238358:T:CF203L0.984
X:70238360:C:AF203L0.984
X:70238360:C:GF203L0.984
X:70239746:T:AV215D0.981
X:70240231:T:CF310L0.979
X:70240233:C:AF310L0.979
X:70240233:C:GF310L0.979
X:70239760:T:CF220L0.977
X:70239762:T:AF220L0.977
X:70239762:T:GF220L0.977
X:70238359:T:CF203S0.969
X:70238371:C:AA207D0.969
X:70237155:T:CF123L0.967
X:70237157:C:AF123L0.967
X:70237157:C:GF123L0.967
X:70237167:T:CF127L0.967
X:70237169:C:AF127L0.967
X:70237169:C:GF127L0.967
X:70237228:G:TR147M0.965
X:70236128:T:CF82L0.963
X:70236130:C:AF82L0.963
X:70236130:C:GF82L0.963
X:70237133:C:AN115K0.963
X:70237133:C:GN115K0.963
X:70237095:C:GH103D0.958
X:70237229:G:CR147S0.958
X:70237229:G:TR147S0.958
X:70238362:T:AV204E0.957
X:70239743:T:AL214Q0.954
X:70239755:T:CF218S0.953

dbSNP variants (sampled 300 via entrez): RS1000328209 (X:70236983 C>G), RS1000680637 (X:70237326 C>A), RS1000746534 (X:70239529 G>T), RS1000908598 (X:70237857 G>A,C,T), RS1001199372 (X:70236694 A>G), RS1002375937 (X:70237855 A>C), RS1002469992 (X:70234544 TG>T,TGG), RS1002667489 (X:70232766 TAAGGA>T), RS1002762080 (X:70235017 A>T), RS1002975897 (X:70239419 T>C), RS1003250808 (X:70239198 C>T), RS1005209484 (X:70238024 G>C), RS1006822624 (X:70239122 C>G), RS1007316386 (X:70240626 A>G), RS1007691882 (X:70240520 C>T)

Disease associations

OMIM: gene MIM:300924 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL2375205 (SINGLE PROTEIN)

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

7 total (human), top 7 by PubMed support.

ChemicalActions (top 5)PubMed papers
CGP 52608affects binding, increases reaction1
clothianidinincreases expression1
Benzo(a)pyreneincreases methylation1
Cadmiumincreases abundance, increases expression1
Nickeldecreases expression1
Tetrachlorodibenzodioxindecreases expression1
Cadmium Chlorideincreases abundance, increases expression1

ChEMBL screening assays

2 unique, capped per target: 2 binding

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL2378918BindingInhibition of human recombinant AWAT1 expressed in insect cell membrane using palmitoleyl alcohol and [14C]stearoyl coenzyme A as substrate after 10 to 15 mins by liquid scintillation countingIdentification and design of a novel series of MGAT2 inhibitors. — Bioorg Med Chem Lett

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.